Giverny Capital
NVO · Medicine & biotech

Novo Nordisk

Makes Ozempic and Wegovy, plus insulin for diabetes.
Sold all
Giverny Capital sold all 12,400 of its Novo Nordisk shares between April and June. On March 31, 2026, they were worth about $455,700.
Mar 31
12,400
Jun 30
None

The numbers

Shares they used to own
12,400
Shares now
0
Value on Mar 31, 2026
$455,700
about $455,700
Kind
Shares
Owned by
None of the funds we follow
More about Novo Nordisk
The value uses the price on Mar 31, 2026. They may have sold at a different price.
See the original filing on SEC.gov
Not investment advice. Holdings come from public SEC reports and the funds’ own letters, and can be up to 4½ months old. How this works